CT2 Program Lecture Series

All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:45 a.m. for those attending the lecture. 

Principles of Cancer Drug Therapeutics Development

This is a required series of 12 weekly lectures delivered by CT2 and UC San Diego faculty members during fall quarter. They focus on the necessary sequential steps in drug development.

Topics in Cancer Drug Development

This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

Upcoming Lectures

Date Speaker Affiliation Title
​Stanley Kim, JD, CEO
Mike Fuller, JD
Global IP Issues/Markets in Biotech
Jay Desgroseller, PhD ​UCSDStemness Suppressors to Combat Aggressive Breast Cancers
​Don Durden, MD, PhD
Death of a Dogma: One drug, one target
Patrick Raber, PhD
​Adaptive Biotechnologies
​Unveiling New Molecular Biomarkers for Immunotherapy Using Immunosequencing
​No Lecture
Paul Maffuid, PhD, VP
Perspectives on the Discovery and Development of Fully Human Antibodies Gained from Targeting Tumor Associated Carbohydrate Antigens
Thomas Ichim, PhD (TBD)
Creative Medical Technology Holdings, Inc.
Title TBA

Schedules for previous years